Categories: Breaking NewsHealth

WHO projections: Nearly 20,000 Ebola cases by November 2014

The World Health Organization (WHO) has warned that Ebola infections will treble to 20,000 by November if efforts to tackle the outbreak are not stepped up.

A new analysis suggests about 70% of those infected have died, higher than the 50% previously reported.

There have been 2,800 deaths so far and the disease remains “a public health emergency of international concern”, the UN agency said.

Trials of experimental drugs are being fast tracked in West Africa.

Meanwhile, more information on the spread and likely scale of the epidemic has emerged.

Projections published in The New England Journal of Medicine suggest by early November there will have been nearly 20,000 cases.

A new analysis of confirmed cases suggests death rates are higher than previously reported at about 70% of all cases.

The WHO has warned that Ebola infections will treble to 20,000 by November 2014 if efforts to tackle the outbreak are not stepped up

And WHO scientists said numbers were predicted to rise exponentially, raising the possibility that the disease could become endemic [regularly found] in West Africa.

Nearly all of the deaths in the world’s worst Ebola outbreak have been recorded in Guinea, Liberia and Sierra Leone.

Dr. Christopher Dye, Director of Strategy for WHO, said projections suggest “unless control measures – including improvements in contract tracing, adequate case isolation, increased quality of care and capacity for clinical management, greater community engagement, and support from international partners – improve quickly, these three countries will soon be reporting thousands of cases and deaths each week”.

Dr. Christopher Dye, co-author of the study, called for “the most forceful implementation of present control measures and for the rapid development and deployment of new drugs and vaccines”.

It came as The Wellcome Trust charity announced that experimental drugs would be tested in West Africa for the first time.

Several drugs are under development, but they have not been fully tested and most are in very short supply.

They include the drug ZMapp, which has been given to a handful of infected health workers.

Dr. Peter Horby, of the Centre for Tropical Medicine and Global Health at the University of Oxford, said the first trials could begin in West Africa as early as November.

Dr. Jeremy Farrar, director of the Wellcome Trust, said therapeutics alone were not an answer.

Kathryn R. Bown

Kathryn - Our health specialist likes to share with the readers the latest news from the field. Nobody understands better than her the relation between healthy mind and healthy body.

Recent Posts

Spain: At Least 158 Killed In The Country’s Worst Flooding Disaster

At least 158 people have died in Spain's worst flooding disaster in generations. On October…

2 days ago

Russia Fines Google $20,000,000,000,000,000,000,000,000,000,000,000, Surpassing Global GDP

Google has been fined two undecillion (a two followed by 36 zeroes) roubles by a…

2 days ago

Financing Your Home Remodel: 7 Tips for Success

Embarking on a home remodel is an exciting journey, promising enhanced comfort, increased property value,…

2 weeks ago

Donald Trump Serves Up McDonald’s Fries While Kamala Harris Celebrates 60th Birthday with Church Choir

The US presidential candidates continued to campaign across key swing states on October 20. Footage…

2 weeks ago

America PAC: Elon Musk Promises to Award $1M Each Day to Swing States Voters

Elon Musk has said he will give away $1 million a day to a registered…

2 weeks ago

Canada Expels 6 Indian Diplomats Amid Khalistan Row

India and Canada have decided to expel their top envoys along with other diplomats as…

3 weeks ago